Impacto do tempo de exposição à doença e do tratamento em pacientes com migrânea

Thaís Brito Vilela; Pedro Henrique Ribeiro da Cunha; Rodrigo Nicolato; Isabela Maria Magalhães Lima

doi:10.25118/2763-9037.2023.v13.472

Autores/as

Thaís Brito Vilela Doutoranda, Medicina Molecular, Universidade Federal de Minas Gerais, UFMG, Belo Horizonte, MG, Brasil https://orcid.org/0000-0003-1144-9631
Pedro Henrique Ribeiro da Cunha Discente, Medicina, Universidade Federal de Minas Gerais, UFMG, Belo Horizonte, MG, Brasil https://orcid.org/0000-0003-3910-4432
Rodrigo Nicolato Docente, Pós Graduação em Medicina Molecular, Universidade Federal de Minas Gerais, UFMG, Belo Horizonte, MG, Brasil https://orcid.org/0000-0003-1585-7720
Isabela Maria Magalhães Lima Docente, Universidade Federal de São João Del-Rei, UFSJ, São João Del-Rei, MG, Brasil https://orcid.org/0000-0002-4549-9576

DOI:

https://doi.org/10.25118/2763-9037.2023.v13.472

Palabras clave:

migraña sin aura, distrés psicológico, edad de inicio, tiempo de tratamiento, trastornos migrañosos, cefaleas

Resumen

Introducción: la migraña es responsable del impacto en la funcionalidad y el sufrimiento psicológico de los individuos que la padecen. La gravedad de los síntomas de la migraña y el tiempo de exposición están asociados y se relacionan con la edad de inicio de la migraña y el tratamiento temprano. Objetivo: El objetivo de este artículo es verificar si existe asociación entre el tiempo de exposición a la migraña y la prevalencia de síntomas depresivos y ansiosos, así como identificar la relación directa o indirecta entre la duración del tratamiento sobre síntomas de trastornos psiquiátricos y la disminución del impacto de la enfermedad de migraña en la vida de los pacientes. Método: esta investigación constituye un estudio descriptivo transversal, realizado en una unidad especializada en atención de pacientes con migraña con una muestra dividida en grupo control, migraña episódica y migraña crónica. Resultados y conclusiones: se concluyó que los pacientes de la misma edad con migraña crónica (MC) o migraña episódica (EM) informaron períodos de inicio de dolor de cabeza similares, pero con un tiempo de tratamiento diferente (CM = 15 meses y EM = 34 meses). Además, el grupo de migraña crónica tenía una mayor carga de enfermedad.

Descargas

Los datos de descargas todavía no están disponibles.

Biografía del autor/a

Thaís Brito Vilela, Doutoranda, Medicina Molecular, Universidade Federal de Minas Gerais, UFMG, Belo Horizonte, MG, Brasil

http://lattes.cnpq.br/7856646392159782

Pedro Henrique Ribeiro da Cunha, Discente, Medicina, Universidade Federal de Minas Gerais, UFMG, Belo Horizonte, MG, Brasil

http://lattes.cnpq.br/3356532054424282

Rodrigo Nicolato, Docente, Pós Graduação em Medicina Molecular, Universidade Federal de Minas Gerais, UFMG, Belo Horizonte, MG, Brasil

http://lattes.cnpq.br/7268639115607517

Isabela Maria Magalhães Lima , Docente, Universidade Federal de São João Del-Rei, UFSJ, São João Del-Rei, MG, Brasil

http://lattes.cnpq.br/6434041086053417

Citas

Chen H, Chen G, Zheng X, Guo Y. Contribution of specific diseases and injuries to changes in health adjusted life expectancy in 187 countries from 1990 to 2013: retrospective observational study. BMJ. 2019;364:l969. https://doi.org/10.1136/bmj.l969 PMID:30917970 - PMCID:PMC6435998

Souza NE, Calumby ML, Afonso EO, Nogueira TZS, Pereira ABCNG. Cefaleia: migrânea e qualidade de vida. Rev Saude. 2015;6(2):23-6. http://editora.universidadedevassouras.edu.br/index.php/RS/article/view/55

Hansen JM, Lipton RB, Dodick DW, Silberstein SD, Saper JR, Aurora SK, Goadsby PJ, Charles A. Migraine headache is present in the aura phase: a prospective study. Neurology. 2012;79(20):2044-9. https://doi.org/10.1212/WNL.0b013e3182749eed - PMID:23115208 - PMCID:PMC3511920

Dodick DW. A phase-by-phase review of migraine pathophysiology. Headache. 2018;58 Suppl 1:4-16. https://doi.org/10.1111/head.13300 PMID:29697154

Organização Mundial da Saúde. Levantamento da incidência de cefaléia no Brasil. 2011. Disponível em: http://www.who.int/healthinfo/statistics/bod_migraine.pdf Acesso em: 5 set. 2015.

Headache classification committee of the International Headache Society (IHS) the international classification of headache disorders, 3rd edition. Cephalalgia. 2018;38(1):1-211. https://doi.org/10.1177/0333102417738202 - PMID:29368949

May A, Schulte LH. Chronic migraine: risk factors, mechanisms and treatment. Nat Rev Neurol. 2016;12(8):455-64. https://doi.org/10.1038/nrneurol.2016.93 - PMID:27389092

Meletiche DM, Lofland JH, Young WB. Quality-of-life differences between patients with episodic and transformed migraine. Headache. 2001;41(6):573-8. https://doi.org/10.1046/j.1526-4610.2001.041006573.x - PMID:11437893

Blumenfeld AM, Varon SF, Wilcox TK, Buse DC, Kawata AK, Manack A, Goadsby PJ, Lipton RB. Disability, HRQoL and resource use among chronic and episodic migraineurs: results from the International Burden of Migraine Study (IBMS). Cephalalgia. 2011;31(3):301-15. https://doi.org/10.1177/0333102410381145 - PMID:20813784

Buse DC, Manack A, Serrano D, Turkel C, Lipton RB. Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers. J Neurol Neurosurg Psychiatry. 2010;81(4):428-32. https://doi.org/10.1136/jnnp.2009.192492 - PMID:20164501

Chen YC, Tang CH, Ng K, Wang SJ. Comorbidity profiles of chronic migraine sufferers in a national database in Taiwan. J Headache Pain. 2012;13(4):311-9. https://doi.org/10.1007/s10194-012-0447-4 PMID:22527034 - PMCID:PMC3356468

Raggi A, Giovannetti AM, Quintas R, D'Amico D, Cieza A, Sabariego C, Bickenbach JE, Leonardi M. A systematic review of the psychosocial difficulties relevant to patients with migraine. J Headache Pain. 2012;13(8):595-606. https://doi.org/10.1007/s10194-012-0482-1 - PMID:23001069 - PMCID:PMC3484254

Schwedt TJ, Garza I. Acute treatment of migraine in adults. Waltham: UpToDate; 2022. https://www.uptodate.com/contents/acute-treatment-of-migraine-in-adults

Puledda F, Shields K. Non-pharmacological approaches for migraine. Neurotherapeutics. 2018;15(2):336-45. https://doi.org/10.1007/s13311-018-0623-6 - PMID:29616493 - PMCID:PMC5935652

Schwedt TJ. Preventive therapy of migraine. Continuum (Minneap Minn). 2018;24(4):1052-65. https://doi.org/10.1212/CON.0000000000000635 - PMID:30074549

Jesus CAS, Peres MFP. Review of major risk factors for chronic migraine. Headache Med. 2012;3(4):181-7. https://doi.org/10.48208/HeadacheMed.2012.28

Wells RE, O'Connell N, Pierce CR, Estave P, Penzien DB, Loder E, Zeidan F, Houle TT. Effectiveness of mindfulness meditation vs headache education for adults with migraine: a randomized clinical trial. JAMA Intern Med. 2021;181(3):317-28. https://doi.org/10.1001/jamainternmed.2020.7090 PMID:33315046 - PMCID:PMC7737157

Spitzer RL, Kroenke K, Williams JBW, Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092-7. https://doi.org/10.1001/archinte.166.10.1092 - PMID:16717171

Santos IS, Tavares BF, Munhoz TN, Almeida LSP, Silva NTB, Tams BD, Patella AM, Matijasevich A. Sensibilidade e especificidade do Patient Health Questionnaire-9 (PHQ-9) entre adultos da população geral. Cad Saude Publica. 2013;29(8):1533-43. https://doi.org/10.1590/S0102-311X2013001200006 PMID:24005919

Arenaza-Urquijo EM, Gonneaud J, Fouquet M, Perrotin A, Mézenge F, Landeau B, Egret S, De la Sayette V, Desgranges B, Chételat G. Interaction between years of education and APOE ε4 status on frontal and temporal metabolism. Neurology. 2015;85(16):1392-9. https://doi.org/10.1212/WNL.0000000000002034 - PMID:26408498 - PMCID:PMC4626241

Van Gerven PWM, Meijer WA, Jolles J. Education does not protect against age-related decline of switching focal attention in working memory. Brain Cogn. 2007;64(2):158-63. https://doi.org/10.1016/j.bandc.2007.02.005 - PMID:17397977

Bao J, Ma M, Dong S, Gao L, Li C, Cui C, Chen N, Zhang Y, He L. Early age of migraine onset is independently related to cognitive decline and symptoms of depression affect quality of life. Curr Neurovasc Res. 2020;17(2):177-87. https://doi.org/10.2174/1567202617666200207130659 PMID:32031072 - PMCID:PMC7536790

Charles JA, Peterlin BL, Rapoport AM, Linder SL, Kabbouche MA, Sheftell FD. Favorable outcome of early treatment of new onset child and adolescent migraine: implications for disease modification. J Headache Pain. 2009;10(4):227-33. https://doi.org/10.1007/s10194-009-0133-3 - PMID:19506799 PMCID:PMC3451739

Hu XH, Ng-Mak D, Cady R. Does early migraine treatment shorten time to headache peak and reduce its severity? Headache. 2008;48(6):914-20. https://doi.org/10.1111/j.1526-4610.2007.00955.x PMID:18005142

Landy SH, Runken MC, Bell CF, Higbie RL, Haskins LS. Examining the interrelationship of migraine onset, duration, and time to treatment. Headache. 2012;52(3):363-73. https://doi.org/10.1111/j.1526-4610.2011.02029.x - PMID:22077159

Gendolla A. Early treatment in migraine: how strong is the current evidence? Cephalalgia. 2008;28 Suppl 2:28-35. https://doi.org/10.1111/j.1468-2982.2008.01688.x - PMID:18715330

Klan T, Liesering-Latta E, Gaul C, Martin PR, Witthoft M. An integrative cognitive behavioral therapy program for adults with migraine: a feasibility study. Headache. 2019;59(5):741-55. https://doi.org/10.1111/head.13532 - PMID:30970172

Galvez-Sánchez CM, Montoro CI, Moreno-Padilla M, Del Paso GAR, de la Coba P. Effectiveness of acceptance and commitment therapy in central pain sensitization syndromes: a systematic review. J Clin Med. 2021;10(12):2706. https://doi.org/10.3390/jcm10122706 - PMID:34205244 PMCID:PMC8235706